Literature DB >> 23511553

Relationship Between Sleep Problems and Quality of Life in Children With ADHD.

Esra Yürümez1, Birim Günay Kılıç2.   

Abstract

OBJECTIVE: The purpose of this study is to assess the sleep behaviors, sleep problems and frequency, and relationship with psychiatric comorbidities in ADHD Combined type and to evaluate the effect of sleep problems on quality of life.
METHOD: Forty-six boys, aged 7 to 13 years, with ADHD-combined type and 31 healthy boys were included. ADHD children were never treated for sleep or psychiatric disorders. Intelligence quotient (IQ) test scores were minimum 80, body mass index were normal and did not have medical disorders. Parents completed Children's Sleep Habits Questionnaire, Conners' Parent Rating Scale and The Pediatric Quality of Life Inventory (PedsQL) and participants were asked about sleep behaviors and were administered PedsQL and Schedule for Affective Disorders and Schizophrenia.
RESULTS: The frequency of sleep problems in ADHD is 84.8%, higher than the control group (p = .002). Evaluating PedsQL scores, the quality of life is worse in physical, psychosocial health, and total life quality (p < .05). ADHD group with sleep problems have more night wakings than control group with sleep problems (p = .02). The comorbidity do not increase sleep problems. The frequency of parasomnias is increased in group with learning disorders (p = .05).
CONCLUSION: The results of this study, which controls for a number of possible confounders found in previous examinations of ADHD and sleep, support the results of a number of other studies that have found an increased overall prevalence of parent-reported sleep disturbances in children with ADHD compared with healthy control participants. As the ADHD group have more night wakings than the control group through the night, it is thought that night wakings that cause a partitioned sleep may be important signs seen in ADHD. That could be suggested by two hypotheses. First one is that, daytime sleepiness is more common in ADHD and those children present excessive hyperactivity during the day to stay awake and the second one is the improvement of ADHD signs when the drugs for sleepiness are used. Usage of standardized and valid diagnostic criteria, exclusion of adolescence, gender, socioeconomic level, primary sleep problems, medical disorders and low IQ level, making allowances for effect of comorbidities and having compared with the control group are the important methodological features of this study. The most important limitation of this study is small sample size that makes the findings less generalizable to other groups of children with ADHD, and another one is not having used objective measurements together with subjective measurements. In conclusion, these results underscore the importance of screening all children who have a symptom constellation suggestive of ADHD for sleep problems that may either play a causative role or exacerbate the clinical appearance of ADHD in a given child. Correct evaluation and treatment of sleep problems increase the life quality of family and child and also decrease the severity of ADHD symptoms.
© The Author(s) 2013.

Entities:  

Keywords:  Children’s Sleep Habits Questionnaire; Pediatric Quality of Life Inventory; attention deficit hyperactivity disorder; life quality; sleep

Mesh:

Year:  2013        PMID: 23511553     DOI: 10.1177/1087054713479666

Source DB:  PubMed          Journal:  J Atten Disord        ISSN: 1087-0547            Impact factor:   3.256


  8 in total

1.  Associations Between Disruptive Behavior Problems, Parenting Factors, and Sleep Problems Among Young Children.

Authors:  Jennifer Coto; Alexis Garcia; Katie C Hart; Paulo A Graziano
Journal:  J Dev Behav Pediatr       Date:  2018 Oct/Nov       Impact factor: 2.225

2.  Sleep habits in children with attention-deficit/hyperactivity disorder predominantly inattentive type and associations with comorbid psychopathology symptoms.

Authors:  Stephen P Becker; Linda J Pfiffner; Mark A Stein; G Leonard Burns; Keith McBurnett
Journal:  Sleep Med       Date:  2015-12-02       Impact factor: 3.492

3.  Meeting the 24-Hour Movement Guidelines and Outcomes in Adolescents with ADHD: A Cross-Sectional Observational Study.

Authors:  Wei Wang; Justin A Haegele; Yandan Wu; Chunxiao Li
Journal:  Int J Environ Res Public Health       Date:  2022-02-14       Impact factor: 3.390

4.  The impact of comorbid mental health symptoms and sex on sleep functioning in children with ADHD.

Authors:  Stephen P Becker; Caroline N Cusick; Craig A Sidol; Jeffery N Epstein; Leanne Tamm
Journal:  Eur Child Adolesc Psychiatry       Date:  2017-10-05       Impact factor: 4.785

5.  Sleep Difficulties in Infancy Are Associated with Symptoms of Inattention and Hyperactivity at the Age of 5 Years: A Longitudinal Study.

Authors:  Hanna Huhdanpää; Isabel Morales-Muñoz; Eeva T Aronen; Pirjo Pölkki; Outi Saarenpää-Heikkilä; Tiina Paunio; Anneli Kylliäinen; E Juulia Paavonen
Journal:  J Dev Behav Pediatr       Date:  2019 Jul/Aug       Impact factor: 2.225

6.  Risk and protective factors related to children's symptoms of emotional difficulties and hyperactivity/inattention during the COVID-19-related lockdown in France: results from a community sample.

Authors:  Cédric Galéra; Maria Melchior; Flore Moulin; Tarik El-Aarbaoui; Joel José Herranz Bustamante; Mégane Héron; Murielle Mary-Krause; Alexandra Rouquette
Journal:  Eur Child Adolesc Psychiatry       Date:  2021-03-09       Impact factor: 5.349

7.  Evaluating the Feasibility and Acceptability of the Lifestyle Enhancement for ADHD Program.

Authors:  Cindy Ola; Erin Gonzalez; Nguyen Tran; Tyler Sasser; Michelle Kuhn; Patrick A LaCount; Mark A Stein; Jason A Mendoza; Pooja S Tandon
Journal:  J Pediatr Psychol       Date:  2021-07-20

8.  Evaluation of the Relationship Between Attention Deficit Hyperactivity Disorder Symptoms and Chronotype.

Authors:  Mahmut Cem Tarakçioğlu; Muhammed Tayyib Kadak; Gözde Akkin Gürbüz; Burç Çağrı Poyraz; Fırat Erdoğan; Umut Mert Aksoy
Journal:  Noro Psikiyatr Ars       Date:  2018-03-19       Impact factor: 1.339

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.